Updated guidelines for lupus nephritis and need for earlier diagnosis. Introduction of risk scoring model using incident proteinuria. Regency clinical trial and obinutuzumab
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
272 of 272 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Nuclear Medicine
- Ophthalmology
- Pediatric Hematology-Oncology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Surgical Oncology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedDec 23, 2025
-
Last day to claim creditDec 24, 2026 2 months left
-
Physicians’ Education Resource Burst CME(TM): Recognizing Lupus Nephritis-From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease
-
Physicians’ Education Resource Burst CME(TM) Part V: Complement Inhibitors in IgAN
-
Physicians’ Education Resource Burst CME(TM) Part IV: Anti-CD38 Therapies in IgAN
-
i3 Health Exploring the Use of Biologics in the Management of Lupus Nephritis: A Clinical Case Conference
-
Answers in CME Inc. (AiCME) Emerging Therapeutic Options for Lupus Nephritis: Preserving Kidney Function and Delaying Progression
-
AchieveCE Systemic Lupus Erythematosus: Diagnosis and Management Across the Lifespan
